Ana Rogovic

Questioner
DISC Type : c

VP International Affiliates DACH & Nordics at Amicus Therapeutics

Munich, Bavaria, Germany

Overview

Ana Rogovic serves as the VP of International Affiliates for DACH & Nordics and Managing Director for Amicus Therapeutics in Germany. Her career is marked by leadership roles in specialized pharmaceuticals at Amgen and Bristol-Myers Squibb. She holds masters degrees in Political Science and International Relations.

She is a passionate advocate for patients with rare diseases, frequently engaging in awareness campaigns. Her public statements emphasize the need for equity in healthcare, better access to therapies, and reducing the daily burden on patients and their families, reflecting a deep commitment to the community her company serves.

Ana represents her company in federal health committee hearings, directly advocating for patient access to new and innovative treatments for rare conditions.

Personality Overview

Cautious & Analytical

Value Seeker

Price-Sensitive

While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.  They are more likely than others to negotiate on pricing and terms. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.

Topics They Care About

Rare Disease Advocacy
Actively raises awareness for the rare disease community through social media and represents Amicus in health policy discussions, focusing on conditions like Fabry disease.
Patient-Centric Therapies
Champions treatments that reduce patient burden, such as the advantages of oral therapies over infusions, to improve the quality of life for patients and their families.
Health Policy
Leverages her background in political science by participating in formal hearings with health authorities like Germany's Federal Joint Committee to shape policy and access.

Media Appearances

Ana has no verified media appearances

Work History

7-2024
VP International Affiliates DACH & Nordics at Amicus Therapeutics
1-2024 - 7-2024
VP International Affiliates DACH at Amicus Therapeutics
1-2022 - 1-2024
Executive Director DACH at Amicus Therapeutics
7-2017 - 1-2020
Business Unit Director Cardiology & Nephrology at Amgen
10-2015 - 6-2017
Business Unit Head General Medicine at Amgen

Education

1998 - 1998
Mag.phil from Universität Wien
1993 - 1997
Master of Arts (MA) from Webster University (AT)

More Information

Social Presence :

Prographics :

Exp : 16 Location : Munich, Bavaria, Germany Job Level : Senior Designation : VP International Affiliates DACH & Nordics at Amicus Therapeutics
URL has been copied!

Insights For Selling To Ana

During A Call Or A Meeting

DO's

  • Share as much information as possible regarding your product
  • Keep some extra margin in hand as they will likely negotiate the pricing
  • Back up any claims with data and numbers

DONT's

  • Don’t overhype the product/pitch, keep it measured
  • Don’t depend too much on anecdotal evidence, it reduces their confidence
  • Don’t try to be too friendly or informal with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Ana is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Ana

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Ana move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Ana take some risk or not?

  • If they believe that they have analyzed the situation well, they can take a little risk.

You And Ana

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.